Jennifer Doudna (Photo by Brian Ach/Getty Images for Wired)

Doud­na re­search team finds CRISPR-Csm de­liv­ery po­ten­tial­ly out­per­forms RNAi, Cas13

While RNAi and Cas13 have been used as some of the ear­ly meth­ods for gene si­lenc­ing, a new preprint from top re­searchers says there might be some­thing bet­ter com­ing down the pike.

A group of UC Berke­ley re­searchers, com­pris­ing famed bio­chemist and No­bel Prize win­ner Jen­nifer Doud­na and her lab mem­bers David Colog­nori and Mare­na Trinidad, has de­scribed a new method that can pro­vide po­ten­tial­ly safer and more ef­fi­cient gene edit­ing: CRISPR-Csm.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.